Wolverine Trading
BBIO icon

Wolverine Trading’s BridgeBio Pharma BBIO Stock Holding History

Wolverine Trading’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.43M Buy
27,600
+6,900
+33% +$337K ﹤0.01% 2512
2025
Q2 		$929K Sell
20,700
-3,200
-13% -$116K ﹤0.01% 2380
2025
Q1 		$839K Sell
23,900
-8,800
-27% -$297K ﹤0.01% 2419
2024
Q4 		$893K Buy
32,700
+18,800
+135% +$486K ﹤0.01% 2775
2024
Q3 		$347K Hold
13,900
– – ﹤0.01% 3445
2024
Q2 		$352K Sell
13,900
-15,400
-53% -$421K ﹤0.01% 3201
2024
Q1 		$906K Buy
29,300
+15,900
+119% +$541K ﹤0.01% 2288
2023
Q4 		$541K Sell
13,400
-14,200
-51% -$426K ﹤0.01% 2873
2023
Q3 		$728K Sell
27,600
-3,400
-11% -$96.5K ﹤0.01% 2396
2023
Q2 		$527K Sell
31,000
-91,600
-75% -$1.38M ﹤0.01% 2553
2023
Q1 		$2.1M Buy
+122,600
New +$1.43M ﹤0.01% 1341
2022
Q1 		– Sell
-26,600
Closed -$387K – 5381
2021
Q4 		$387K Buy
26,600
+19,800
+291% +$838K ﹤0.01% 3796
2021
Q3 		$324K Sell
6,800
-3,600
-35% -$193K ﹤0.01% 4585
2021
Q2 		$625K Sell
10,400
-500
-5% -$28.6K ﹤0.01% 3373
2021
Q1 		$644K Buy
+10,900
New +$713K ﹤0.01% 3350

Other funds holding BBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's BBIO Position: Q3 2025 in Review

Wolverine Trading increased its BridgeBio Pharma (BBIO) stake by 50% in Q3 2025, buying an estimated $808K and bringing the position to 49,886 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Wolverine Trading first reported a position in BBIO in Q1 2021 and has held it in 10 quarters since. 392 funds tracked by Wall St. Rank hold BBIO as of Q3 2025.

  • Wolverine Trading held 49,886 shares of BridgeBio Pharma worth $2.59M as of Q3 2025.
  • Wolverine Trading bought 16,564 BridgeBio Pharma shares in Q3 2025, an estimated $808K.
  • BridgeBio Pharma made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1950 holding.
  • Wolverine Trading first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 10 quarters since.
  • 392 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.